ArticleProceedings of the National Academy of Sciences of the United States of America2003

Chemically programmed monoclonal antibodies for cancer therapy: adaptor immunotherapy based on a covalent antibody catalyst.

Christoph Rader et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.